Drug Dev
J&J Innovation talks CNS partnering and Alzheimer's challenges
J&J Innovation's senior director of neuroscience innovation, Prof. John Isaac, talks to Scrip on the sidelines of the BIO-Europe Spring partnering meeting in Amsterdam about the unmet needs in neurology and the partnering approach J&J Innovation has for the development of new therapeutics for devastating neurodegenerative conditions such as Alzheimer's disease.